Evidence map›Paper›PMID 30647486›Full record

ArticleReumatologia2018

Vitamin D serum concentration is not related to the activity of spondyloarthritis - preliminary study.

Zofia Guła, Anna Kopczyńska, Karolina Hańska, Maciej Słomski, Jarosław Nowakowski, Beata Kwaśny-Krochin, Jerzy Gąsowski, Mariusz Korkosz

Open access · diamondAbstract read
In one paragraph

Article in Reumatologia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zofia GułaDepartment of Rheumatology and Balneology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Anna KopczyńskaStudents Scientific Group, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Karolina HańskaStudents Scientific Group, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Maciej SłomskiStudents Scientific Group, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Jarosław NowakowskiDepartment of Rheumatology and Balneology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Beata Kwaśny-KrochinDepartment of Rheumatology and Balneology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Jerzy GąsowskiChair of Internal Diseases and Gerontology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Mariusz KorkoszDepartment of Rheumatology and Balneology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveVitamin D plays an important role in mineral turnover and bone remodeling and there are increasing data about its immunomodulatory potential in different rheumatologic disorders. Deficiency of vitamin D is frequent in patients with spondyloarthritis (SpA) and some data suggest its association with increased disease activity and structural damage. However, its exact role in the pathogenesis of SpA and its association with disease activity are still a matter of debate. MATERIAL AND

methodsA cross-sectional study of patients diagnosed with axial spondyloarthritis (axSpA) and peripheral spondyloarthritis (perSpA) according to Assessment of Spondyloarthritis International Society classification criteria was performed. The correlation between concentration of 25-hydroxyvitamin D - 25(OH)D - and disease activity scores (Bath Ankylosing Spondylitis Disease Activity Index - BASDAI, Ankylosing Spondylitis Disease Activity Score - ASDAS), inflammatory markers (C-reactive protein - CRP, erythrocyte sedimentation rate - ESR) and clinical symptoms (arthritis, enthesitis, dactylitis) was performed.

resultsWe included 40 patients with axSpA and 23 patients with perSpA. The mean concentration of 25(OH)D was 24.9 ng/ml (SD 12.49). Forty-seven (74.6%) patients had 25(OH)D below the recommended threshold (< 30 ng/ml). We found no statistically significant negative correlation between the level of 25(OH)D and disease activity of axSpA and perSpA in terms of clinical symptoms (arthritis, enthesitis, dactylitis), inflammatory markers (ESR, CRP) and disease activity scores (BASDAI, ASDAS). These results did not change after adjustment for supplementation of vitamin D and seasonal variation.

conclusionsOur data show no correlation between the concentration of 25(OH)D in the serum and disease activity in two subgroups of SpA. However, this does not exclude the potential role of vitamin D in pathogenesis of SpA. Further studies are required to evaluate the optimal range of 25(OH)D serum concentration in axSpA and perSpA patients with its possible immunomodulatory potential and influence on disease activity.

Indexed as

disease activityspondyloarthritisvitamin D deficiency

Identifiers

PMID30647486
PMCPMC6330676
OpenAlexW2908281133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.